Several biocompatible polymers are capable of large responses to small temperature changes around 37ºC. In water, their responses include shrinkage and swelling as well as transitions in wettability. These properties have been harnessed for biomedical applications such as tissue engineering scaffolds and drug delivery carriers. A soft material/hard material hybrid in which a magnetic metal or oxide is embedded in a temperatureresponsive polymer matrix can combine the thermal sensitivity with magnetic signatures. Importantly, nanosizing such construct brings about new desirable features of extremely fast thermal response time, small magnetic hysteresis and enhanced magnetic susceptibility. Remote magnetic maneuvering and heating of the hybrid nanocolloids makes possible such applications as high-throughput enzyme separation and cell screening. Robust drug release on demand may also be obtained using these colloids and nanoparticle-derived thin film devices of combined thermal magnetic sensitivity.
. can again incorporate hydrophobic drugs.
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The volume reduction of the colloid is obviously accompa-279 nied by water rejection. Accordingly, bulk or shell diffusivity 280 may change significantly. In the case of hydrogel, there 281 Figure 5 Temperature-responsive transition manifested by a diameter reduction above the LCST. F69 refers to nanocapsules having a shell made of a bilayer of the PEO-PPO-PEO triblock copolymer known as Pluronic ® F68. Its structure is similar to that illustrated in Fig. 4(b) . F68-EDC refers to similar nanocapsules in which the outer PEO shell is crosslinked by gelatin, which in turn is crosslinked by EDC. Its structure is similar to that illustrated in Fig. 4(c) . F68-IO refers to fully crosslinked nanocapsules that additionally contain iron oxide nanoparticles in the core as illustrated in Fig. 4(d) . The LCST may be identified with the inflection point of the size-temperature curve. The LCST is lower in F68-EDC and F68-IO mostly because the additive (NPC, see caption of Fig. 4 ), which reacts with PEO to render it crosslinkable, is less hydrophilic than PEO. Crosslinking constrains swelling at low temperature, so F68-EDC is smaller than F68 below the LCST. Filling the core with iron oxide nanoparticles further reduces shrinkage above the LCST. solution may be used as one part of the feedstock in the 365 double-emulsion procedure to form the hydrophilic core of 366 a PEO-PPO-PEO colloid ( Fig. 4(a,b) ). Alternatively, inter-367 nal precipitation in the hydrophilic core which contains a 368 Fe(II)/Fe(III) solution may be triggered by a pH increase 369 after the formation of the colloid (Fig. 4(e) ). For hydropho-370 bic cores, hydrophobic IO nanoparticles need to be first 371 synthesized, which typically involves high temperature pre-372 cipitation in a long-chain alcohol such as oleic acid [38, 39] .
U N C O R R E C T E D P R O O F
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The oily IO can then be used in the emulsion procedure to 374 enter the hydrophobic core. Since the procedure to grow 375 spherical oily IO nanoparticles of a narrow size distribution 376 from 3 to 20 nm ( Fig. 6(a-d) ) is rather well developed, it may Half-life (t 50 ) for drug release (typically a small molecule) from particles with and without magnetic heating. t 50 is the time to reach M t /M ∞ = 0.5, where M t /M ∞ is the amount released at time t normalized by the total amount of drug contained (see Fig. 8 ). Much faster release with magnetic heating. 
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